Expensive cancer meds improve health, produce savings

06/10/2013 | Forbes

Economic and clinical data show that patients get increasingly more for their money when it comes to new drugs and technological advances, writes Dr. Scott Gottlieb, a former FDA official and a resident fellow at the American Enterprise Institute. New drugs carry high prices, he writes, but they have allowed outpatient care that prevents even more expensive hospital stays.

View Full Article in:


Published in Brief: